NEXVIADYME

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Italy, Lithuania, Romania, Spain, UK.

Active ingredients

The drug NEXVIADYME contains one active pharmaceutical ingredient (API):

1	Avalglucosidase alfa UNII EO144CP0X9 - AVALGLUCOSIDASE ALFA
	Avalglucosidase alfa is a recombinant human acid α-glucosidase (rhGAA) that provides an exogenous source of GAA. Binding to M6P receptors on the cell surface has been shown to occur via carbohydrate groups on the GAA molecule, after which it is internalised and transported into lysosomes, where it undergoes proteolytic cleavage that results in increased enzymatic activity to degrade glycogen.
	Read more about Avalglucosidase alfa

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NEXVIADYME Powder for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A16AB22		A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	3046744, 3046755, 3046766, 3046777
ES	Centro de información online de medicamentos de la AEMPS	1211579001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	117321
FR	Base de données publique des médicaments	64805678
IT	Agenzia del Farmaco	050184011, 050184023, 050184035, 050184047
LT	Valstybinė vaistų kontrolės tarnyba	1095035, 1095036, 1095037, 1095038
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68944001